Bayer to buy BIVI's Cydectin parasiticidesDecember 13, 2016Bayer Animal Health of Shawnee, Kan., will acquire BIVI’s Cydectin (moxidectin) line, which is formulated to control parasites in cattle and sheep, the companies announced Dec. 7.
Education Center - SponsoredVector-Borne Disease Pathogens, Climate Change, and One Healthby • Antech, part of Mars Science & DiagnosticsTo help veterinary professionals better understand the relationship between climate change, VBD pathogen proliferation, and the diagnostic solutions available for detection, Drs. Michelle and Graham answer your pressing clinical questions.
New feline core vaccine available from BIVIAugust 18, 2016Boehringer Ingelheim Vetmedica Inc. has released a reduced-volume core vaccine for cats. The nonadjuvanted Ultra Hybrid FVRCP is administered in a 0.5 mL subcutaneous dose to protect against feline herpesvirus, calicivirus infection and distemper in cats at least 8 weeks old.
